John Lamont
Papers
1
Total Citations
1
H-Index
1
About
John Lamont is a leading figure in the advancement of systems medicine and personalised health, with a career dedicated to bridging the translational gap between laboratory innovation and direct patient benefit. His research focuses on integrating clinical chemistry with personalised therapy, championing a patient-first approach to redefine how complex diseases are diagnosed and treated. Lamont’s most notable contribution is his central role in the prestigious Santorini Conference series, a biannual forum that convenes global experts from the International Federation of Clinical Chemistry (IFCC) and the European Federation of Clinical Chemistry. His work, including the widely-cited 2023 proceedings from the 10th conference, synthesises cutting-edge discussions on systems medicine, emphasising the odyssey from theoretical hope to practical, patient-centric care. By fostering interdisciplinary dialogue, Lamont has helped shape the strategic direction of personalised health, ensuring that clinical laboratory science evolves in lockstep with therapeutic innovation. His impact is measured not just in citations, but in his enduring influence on the global conversation around translating molecular insights into tangible clinical outcomes.
Research Focus
Key Achievements
Top Papers
- 1